A Comprehensive Review on Elastin-Like Polypeptides (ELPs): Characterizations, Synthesis, Purification and Application as Nanoparticles in Drug Delivery of Cancer

Authors

  • Saghar Yousefnia Department of Cell & Molecular Biology, Semnan University, Semnan, Iran

Keywords:

Cancer, Elastin-like polypeptides (ELPs), Inverse transition temperature (ITT), Chemotherapeutic drugs, ELP nanoparticles

Abstract

Cancer is the most challenging disease with high rates of prevalence and mortality in the world. Traditional therapies of cancer include surgery, radiation therapy, and chemotherapy are often unsuccessful in some patients with tumor recurrence. Recently, application of nanoparticles and nanomaterials have developed based on targeted therapy to decrease side effects and non-specificity of current treatments. Elastin like-polypeptides (ELPs) are synthetic and temperature-sensitive biopolymers in the form of repeating polypeptides that attract attention of researchers to use in biomedical applications due to exhibiting some outstanding features such as inverse transition temperature (ITT), high biocompatibility, biodegradability, self-assembly and stability. This review deals with characterizations of ELP, de novo synthesis and purification. In addition, it highlights some applications of ELP in protein purification, biomedical application, tissue engineering, vaccine carriers as well as usage as a drug delivery system. Moreover, it summarizes application of anti-cancer chemotherapeutic drugs, small molecules, peptides and proteins conjugated-ELP as drug delivery in treatment of cancer with introducing soluble ELP Unimers, injectable ELP nanoparticles and ELP block copolymer nanoparticles. These promising approaches could open a way to introduce novel strategies to combat various types of cancer.

Downloads

Download data is not yet available.

References

Yousefnia S, Negahdary M. Role of miRNAs in Cancer: Oncogenic and Tumor Suppressor miRNAs, Their Regulation and Therapeutic Applications. Interdisciplinary Cancer Research. 2024, 23, 593-619. DOI: 10.1007/16833_2024_370

Yousefnia S. Mechanistic Role of circRNAs in Malignant Characterizations of Cancer Stem Cells. Journal of Cancer Biomoleculars and Therapeutics. 2025, 2(3), 19-28. DOI: 10.62382/jcbt.v2i3.67

Nasri N, Saharkhiz S, Dini G, Yousefnia S. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer. International Journal of Pharmaceutics. 2023, 648, 123606. DOI: 10.1016/j.ijpharm.2023.123606

Saharkhiz S, Nasri N, Dini G, Yousefnia S. Development of a new smart theranostic anti-PSMA-aptamer conjugated cationic-lipid coated mesoporous silica platform for targeted delivery of paclitaxel and CdSe/ZnS quantum dots to LNCaP cell line. Journal of Drug Delivery Science and Technology. 2023, 88, 104964. DOI: 10.1016/j.jddst.2023.104964

Yousefnia S, Negahdary M. Diagnostic application of aptamers against leukemia, multiple myeloma and lymphoma: A review. Journal of Drug Delivery Science and Technology. 2024, 100, 106103. DOI: 10.1016/j.jddst.2024.106103

Yousefnia S. A comprehensive review on lncRNA LOXL1-AS1: molecular mechanistic pathways of lncRNA LOXL1-AS1 in tumorigenicity of cancer cells. Frontiers in Oncology. 2024, 14, 1384342. DOI: 10.3389/fonc.2024.1384342

Rahimi G, Yousefnia S, Angnes L, Negahdary M. Design a PEGylated nanocarrier containing lemongrass essential oil (LEO), a drug delivery system: Application as a cytotoxic agent against breast cancer cells. Journal of Drug Delivery Science and Technology. 2023, 80, 104183. DOI: 10.1016/j.jddst.2023.104183

Fletcher EE, Yan D, Kosiba AA, Zhou Y, Shi H. Biotechnological applications of elastin-like polypeptides and the inverse transition cycle in the pharmaceutical industry. Protein Expression and Purification. 2019, 153, 114-120. DOI: 10.1016/j.pep.2018.09.006

Jana S, Stöbener DD, Richard H. Thermoresponsive “Smart” Polymer Systems for Drug Delivery, Gene Therapy and Tissue Engineering. Smart Systems in Biotechnology. 2024, 1-67. DOI: 10.1201/9781003328919-1

Shi X, Chen D, Liu G, Zhang H, Wang X, Wu Z, et al. Application of elastin-like polypeptide in tumor therapy. Cancers. 2022, 14(15), 3683. DOI: 10.3390/cancers14153683

Saxena R, Nanjan MJ. Elastin-like polypeptides and their applications in anticancer drug delivery systems: a review. Drug Delivery. 2015, 22(2), 156-167. DOI: 10.3109/10717544.2013.853210

Lima LF, Sousa MGDC, Rodrigues GR, de Oliveira KBS, Pereira AM, da Costa A, et al. Elastin-like polypeptides in development of nanomaterials for application in the medical field. Frontiers in Nanotechnology. 2022, 4, 874790. DOI: 10.3389/fnano.2022.874790

Wirtz BM, Yun AG, Wick C, Gao XJ, Mai DJ. Protease-Driven Phase Separation of Elastin-Like Polypeptides. Biomacromolecules. 2024, 25(8), 4898-4904. DOI: 10.1021/acs.biomac.4c00346

Choi JW, Choi SH, Won JI. Self-assembly behavior of elastin-like polypeptide diblock copolymers containing a charged moiety. Biomacromolecules. 2021, 22(6), 2604-2613. DOI: 10.1021/acs.biomac.1c00322

Ciofani G, Genchi GG, Mattoli V, Mazzolai B, Bandiera A. The potential of recombinant human elastin-like polypeptides for drug delivery. Expert Opinion on Drug Delivery. 2014, 11(10), 1507-1512. DOI: 10.1517/17425247.2014.926885

López Barreiro D, Minten IJ, Thies JC, Sagt CMJ. Structure–property relationships of elastin-like polypeptides: a review of experimental and computational studies. ACS Biomaterials Science & Engineering. 2023, 9(7), 3796-3809. DOI: 10.1021/acsbiomaterials.1c00145

Phan A, MacKay JA. Steric stabilization of bioactive nanoparticles using elastin-like polypeptides. Advanced Drug Delivery Reviews. 2024, 206, 115189. DOI: 10.1016/j.addr.2024.115189

Varanko AK, Su JC, Chilkoti A. Elastin-Like Polypeptides for Biomedical Applications. Annual Review of Biomedical Engineering. 2020, 22, 343-369. DOI: 10.1146/annurev-bioeng-092419-061127

Riziotis IG, Lamprou P, Papachristou E, Mantsou A, Karolidis G, Papi R, et al. De novo synthesis of elastin-like polypeptides (ELPs): An applied overview on the current experimental techniques. ACS Biomaterials Science & Engineering. 2021, 7(11), 5064-5077. DOI: 10.1021/acsbiomaterials.1c00329

Nelson DW, Connor A, Shen Y, Gilbert RJ. Construction of an Elastin-like Polypeptide Gene in a High Copy Number Plasmid Using a Modified Method of Recursive Directional Ligation. SynBio. 2024, 2(2), 174-189. DOI: 10.3390/synbio2020010

Pereira AM, Costa AD, Dias SC, Casal M, Machado R. Production and purification of two bioactive antimicrobial peptides using a two-step approach involving an elastin-like fusion tag. Pharmaceuticals. 2021, 14(10), 956. DOI: 10.3390/ph14100956

Prabhala SV, Wood DW. Single-step non-chromatographic purification of recombinant mammalian proteins using a split intein ELP tag system. Methods in Molecular Biology. 2023, 2699, 237-253. DOI: 10.1007/978-1-0716-3362-5_13

Rai K, Chu X, Zhou D, Li F, Yang J, Lin J, et al. Development of a protein-solubilizing expression method based on the synergistic action of intein ΔI-CM and the solubility enhancer elastin-like polypeptide. Biochemical Engineering Journal. 2021, 167, 107900. DOI: 10.1016/j.bej.2020.107900

Attia SA, Truong AT, Phan A, Lee SJ, Abanmai M, Markanovic M, et al. αB-Crystallin Peptide Fused with Elastin-like Polypeptide: Intracellular Activity in Retinal Pigment Epithelial Cells Challenged with Oxidative Stress. Antioxidants. 2023, 12(10), 1817. DOI: 10.3390/antiox12101817

Zhao C, Xiao Y, Ling S, Pei Y, Ren J. Recombination and Purification of Elastin-Like Polypeptides. Methods in Molecular Biology. 2021, 2347, 97-103. DOI: 10.1007/978-1-0716-1574-4_9

Hassouneh W, Christensen T, Chilkoti A. Elastin-Like Polypeptides as a Purification Tag for Recombinant Proteins. Current Protocols in Protein Science. 2010, 6, 6.11.1-6.11.16. DOI: 10.1002/0471140864.ps0611s61

Georgilis E, Abdelghani M, Pille J, Aydinlioglu E, van Hest JCM, Lecommandoux S, et al. Nanoparticles based on natural, engineered or synthetic proteins and polypeptides for drug delivery applications. International Journal of Pharmaceutics. 2020, 586, 119537. DOI: 10.1016/j.ijpharm.2020.119537

Jiang D, Yang Y, Yang X, Wang B, Fan W, Liu Y, et al. The application of elastin-like peptides in cancer, tissue engineering and ocular disease. OpenNano. 2023, 9, 100113. DOI: doi.org/10.1016/j.onano.2022.100113

Bidwell GL 3rd. Novel protein therapeutics created using the elastin-like polypeptide platform. Physiology. 2021, 36(6), 367-381. DOI: 10.1152/physiol.00026.2021

Girotti A, González-Valdivieso J, Alonso-Sampedro I, Escalera-Anzola S, Ramos-Díez S, Arias FJ. Elastin-like polymers as nanovaccines: protein engineering of self-assembled, epitope-exposing nanoparticles. Methods in Molecular Biology. 2022, 2465, 41-72. DOI: 10.1007/978-1-0716-2168-4_3

Guo Y, Liu S, Jing D, Liu N, Luo X. The construction of elastin-like polypeptides and their applications in drug delivery system and tissue repair. Journal of Nanobiotechnology. 2023, 21(1), 418. DOI: 10.1186/s12951-023-02184-8

Jenkins IC, Milligan JJ, Chilkoti A. Genetically encoded elastin‐like polypeptides for drug delivery. Advanced Healthcare Materials. 2021, 10(13), e2100209. DOI: 10.1002/adhm.202100209

Hwang J, Huang H, Sullivan MO, Kiick KL. Controlled delivery of vancomycin from collagen-tethered peptide vehicles for the treatment of wound infections. Molecular Pharmaceutics. 2023, 20(3), 1696-1708. DOI: 10.1021/acs.molpharmaceut.2c00898

Patel PR, Haemmerich D. Review on electrospray nanoparticles for drug delivery: Exploring applications. Polymers for Advanced Technologies. 2024, 35(7), e6507. DOI: 10.1002/pat.6507

Wu J. The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application. Journal of Personalized Medicine. 2021, 11(8), 771. DOI: 10.3390/jpm11080771

MacEwan SR, Chilkoti A. Applications of elastin-like polypeptides in drug delivery. Journal of Controlled Release. 2014, 190, 314-330. DOI: 10.1016/j.jconrel.2014.06.028

Khopade S, Agnihotri TG, Baviskar S, Pavar B, Gomte SS, Maskar T, et al. Sublingual Delivery of Human GLP-1 Loaded Nanoliposomal Hydrogel for Treatment of Type 2 Diabetes Mellitus. AAPS PharmSciTech. 2025, 26(5), 155. DOI: 10.1208/s12249-025-03152-1

Walker L, Perkins E, Kratz F, Raucher D. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative. International Journal of Pharmaceutics. 2012, 436(1-2), 825-832. DOI: 10.1016/j.ijpharm.2012.07.043

Dragojevic S, Mackey R, Raucher D. Evaluation of elastin-like polypeptides for tumor targeted delivery of doxorubicin to glioblastoma. Molecules. 2019, 24(18), 3242. DOI: 10.3390/molecules24183242

Shen LX, Zhou P, Wang YM, Zhu ZX, Yuan Q, Cao SQ, et al. Supramolecular nanoparticles based on elastin-like peptides modified capsid protein as drug delivery platform with enhanced cancer chemotherapy efficacy. International Journal of Biological Macromolecules. 2024, 256, 128107. DOI: 10.1016/j.ijbiomac.2023.128107

Shi P, Aluri S, Lin YA, Shah M, Edman M, Dhandhukia J, et al. Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo. Journal of Controlled Release. 2013, 171(3), 330-338. DOI: 10.1016/j.jconrel.2013.05.013

Peddi S, Pan XL, MacKay JA. Intracellular delivery of Rapamycin from FKBP elastin-like polypeptides is consistent with macropinocytosis. Frontiers in Pharmacology. 2018, 9, 1184. DOI: 10.3389/fphar.2018.01184

Bhattacharyya J, Bellucci JJ, Weitzhandler I, McDaniel JR, Spasojevic I, Li XH, et al. A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models. Nature Communications. 2015, 6, 7939. DOI: 10.1038/ncomms8939

Kobatake E, Ikeda Y, Mie M. Construction of protein nanoparticles for targeted delivery of drugs to cancer cells. Materials Advances. 2022, 3, 6262-6269. DOI: 10.1039/D2MA00419D

Goel R, Gulwani D, Singh TD. Synthesis and characterization of IL-4R ligand mimic (AP1)-functionalized elastin-like polypeptide-based nanopolymers as selective delivery vehicles for paclitaxel in ovarian cancer. Cancer Research. 2025, 85, 6893-6893. DOI: 10.1158/1538-7445.AM2025-6893

Vallejo R, Gonzalez-Valdivieso J, Santos M, Rodriguez-Rojo S, Arias F. Production of elastin-like recombinamer-based nanoparticles for docetaxel encapsulation and use as smart drug-delivery systems using a supercritical anti-solvent process. Journal of Industrial and Engineering Chemistry. 2021, 93, 361-374. DOI: 10.1016/j.jiec.2020.10.013

Ramamurthi D, Selvaraj J, Raj PV, Tallapaneni V, Chandrasekar MJN. Downregulation of NT5C3 gene expressions by elastin-like polypeptide gemcitabine conjugate for ovarian cancer therapy. Journal of Drug Delivery Science and Technology. 2022, 76, 103821. DOI: 10.1016/j.jddst.2022.103821

Mie M, Matsumoto R, Mashimo Y, Cass AE, Kobatake E. Development of drug-loaded protein nanoparticles displaying enzymatically-conjugated DNA aptamers for cancer cell targeting. Molecular Biology Reports. 2019, 46, 261-269. DOI: 10.1007/s11033-018-4467-2

Liu WG, McDaniel J, Li XH, Asai D, Quiroz FG, Schaal J, et al. Brachytherapy using injectable seeds that are self-assembled from genetically encoded polypeptides in situ. Cancer Research. 2012, 72(22), 5956-5965. DOI: 10.1158/0008-5472.CAN-12-2127

Hong J, Sim D, Lee BH, Sarangthem V, Park RW. Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy. Journal of Nanobiotechnology. 2024, 22, 293. DOI: 10.1186/s12951-024-02559-5

Avila H, Yu JM, Boddu G, Phan A, Truong A, Peddi S, et al. Hydra-Elastin-like polypeptides increase rapamycin potency when targeting cell surface GRP78. Biomacromolecules. 2022, 23(8), 3116-3129. DOI: 10.1021/acs.biomac.2c00048

Jiang A, Guan XQ, He LP, Guan XG. Engineered elastin-like polypeptides: An efficient platform for enhanced cancer treatment. Frontiers in Pharmacology. 2023, 13, 1113079. DOI: 10.3389/fphar.2022.1113079

Ryu JS, Raucher D. Anti-tumor efficacy of a therapeutic peptide based on thermo-responsive elastin-like polypeptide in combination with gemcitabine. Cancer Letters. 2014, 348(1-2), 177-184. DOI: 10.1016/j.canlet.2014.03.021

Sarangthem V, Kim Y, Singh TD, Seo B-Y, Cheon SH, Lee YJ, et al. Multivalent targeting based delivery of therapeutic peptide using AP1-ELP carrier for effective cancer therapy. Theranostics. 2016, 6(12), 2235-2249. DOI: 10.7150/thno.16425

Liu N, Cui MY, Hu NN, Yang FX, Mu YT, Guo C, et al. An engineered three-in-one hybrid nanosystem from elastin-like polypeptides for enhanced cancer suppression. Colloids and Surfaces B: Biointerfaces. 2022, 220, 112976. DOI: 10.1016/j.colsurfb.2022.112976

Ryu JS, Robinson L, Raucher D. Elastin-like polypeptide delivers a Notch inhibitory peptide to inhibit tumor growth in combination with paclitaxel. Journal of Chemotherapy. 2019, 31(1), 23-29. DOI: 10.1080/1120009X.2018.1537554

Huang KZ, Duan NJ, Zhang CM, Mo R, Hua ZC. Improved antitumor activity of TRAIL fusion protein via formation of self-assembling nanoparticle. Scientific Reports. 2017, 7, 41904. DOI: 10.1038/srep41904

Hu J, Wang GL, Liu XY, Gao WP. Enhancing pharmacokinetics, tumor accumulation, and antitumor efficacy by elastin‐like polypeptide fusion of interferon alpha. Advanced Materials. 2015, 27(45), 7320-7324. DOI: 10.1002/adma.20150344

Liang P, Wang GH, Liu XY, Wang ZR, Wang J, Gao WP. Spatiotemporal combination of thermosensitive polypeptide fused interferon and temozolomide for post-surgical glioblastoma immunochemotherapy. Biomaterials. 2021, 264, 120447. DOI: 10.1016/j.biomaterials.2020.120447

Cao SJ, Lv ZQ, Guo S, Jiang GP, Liu HL. An Update-Prolonging the action of protein and peptide drugs. Journal of Drug Delivery Science and Technology. 2021, 61, 102124. DOI: 10.1016/j.jddst.2020.102124

Simon L, Zhou DX, Coeurvolan A, Lapinte V, Lecommandoux S, Garanger E, et al. Dual Responsive Emulsions Based on Amphiphilic Elastin-like Polypeptide Bioconjugates. Bioconjugate Chemistry. 2024, 35, 1923-1932. DOI: 10.1021/acs.bioconjchem.4c00412

Dai M, Georgilis E, Goudounet G, Garbay B, Pille J, van Hest JC, et al. Refining the design of diblock elastin-like polypeptides for self-assembly into nanoparticles. Polymers. 2021, 13, 1470. DOI: 10.3390/polym13091470

Wang HY, Cai L, Paul A, Enejder A, Heilshorn SC. Hybrid elastin-like polypeptide–polyethylene glycol (ELP-PEG) hydrogels with improved transparency and independent control of matrix mechanics and cell ligand density. Biomacromolecules. 2014, 15, 3421-3428. DOI: 10.1021/bm500969d

Pande S. Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes. Artificial Cells, Nanomedicine, and Biotechnology. 2023, 51(10), 428-440. DOI: 10.1080/21691401.2023.2247036

Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022, 8(5), e09394. DOI: 10.1016/j.heliyon.2022.e09394

Kumari S, Raturi S, Kulshrestha S, Chauhan K, Dhingra S, András K, et al. A comprehensive review on various techniques used for synthesizing nanoparticles. Journal of Materials Research and Technology. 2023, 27, 1739-1763. DOI: 10.1016/j.jmrt.2023.09.291

van Strien J, Escalona-Rayo O, Jiskoot W, Slütter B, Kros A. Elastin-like polypeptide-based micelles as a promising platform in nanomedicine. Journal of Controlled Release. 2023, 353, 713-726. DOI: 10.1016/j.jconrel.2022.12.033

Yeboah A, Cohen RI, Rabolli C, Yarmush ML, Berthiaume F. Elastin-like polypeptides: A strategic fusion partner for biologics. Biotechnology and Bioengineering. 2016, 113(8), 1617-1627. DOI: 10.1002/bit.25998

Downloads

Published

2026-01-06

How to Cite

Yousefnia, S. (2026). A Comprehensive Review on Elastin-Like Polypeptides (ELPs): Characterizations, Synthesis, Purification and Application as Nanoparticles in Drug Delivery of Cancer. Journal of Cancer Biomoleculars and Therapeutics, 3(1), 1–12. Retrieved from https://jcbt.eternopublisher.com/index.php/jcbt/article/view/73